Psoralens


Psoralens are a class of pharmaceutical active ingredients (APIs) that belong to the subcategory of drugs used in the treatment of various skin conditions. These organic compounds are widely known for their photoreactive properties, making them particularly effective in photochemotherapy, also known as psoralen plus ultraviolet A (PUVA) therapy.

Psoralens function by sensitizing the skin to ultraviolet radiation, specifically UVA wavelengths. When administered orally or topically, psoralens penetrate the skin and interact with DNA, forming covalent bonds upon exposure to UVA light. This process helps modulate cellular functions and suppress abnormal cell growth, making it a valuable treatment option for conditions such as psoriasis, vitiligo, and eczema.

Psoralens come in various forms, including methoxsalen, trioxsalen, and bergapten, among others. These compounds are typically sourced from natural plant extracts, such as figs, limes, and celery seeds. However, synthetic variants are also available.

When using psoralens, it is crucial to ensure proper dosage and exposure to UVA light, as excessive or inadequate levels can lead to adverse effects, including burns and skin damage. Therefore, close medical supervision and adherence to prescribed treatment regimens are vital.

Psoralens have gained recognition as an effective therapy for dermatological conditions, and ongoing research continues to explore their potential applications. As with any pharmaceutical API, it is important to consult healthcare professionals for guidance and follow their recommendations for safe and optimal usage.

NameCAS number
Methoxsalen298-81-7
Trioxsalen3902-71-4